Normal development and neoplasia: the imprinting connection.
The observation that a number of autosomal genes are expressed in a parent of origin-dependent monoallelic manner has fuelled a frantic research effort into the underlying mechanisms and biological functions of this phenomenon, termed genomic or parental imprinting. The level of intrigue associated with this subject has been heightened by the discovery that the "transcriptional phenotype" of some imprinted genes shows developmental and tissue-specific variation, and that some imprinted genes are expressed biallelically in tumors. Here we describe some further examples of variation in the allele-specific transcription of an imprinted gene, human IGF2. Analysis of different sub-clones of an established tumor cell line (Jeg-3) revealed examples of both a switch from monoallelic to biallelic expression, as well as monoallelic expression from the opposite parental allele. Examination of IGF2 expression in adult human liver clearly demonstrated that the functional imprinting is manifested in a promoter-specific manner. The P1 promoter produced biallelically derived transcripts, whereas the remaining three promoters were utilized in a complex pattern of mono- and biallelic expression which varied from sample to sample. These observations emphasize the need to re-examine the imprinting phenomenon and its plasticity in terms of the cis elements and trans-acting factors involved in the transcriptional regulation of these genes both in the normal and pathological contexts.
Ohlsson
R
R
Department of Animal Development and Genetics, Uppsala University, Sweden.
Franklin
G
G
D000328:Adult; D000375:Aging / Q000502:physiology*; D000818:Animals; D002648:Child; D005314:Embryonic and Fetal Development; D018392:Genomic Imprinting; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007335:Insulin-Like Growth Factor II / Q000096:biosynthesis*; D008099:Liver / Q000196:embryology* / Q000254:growth & development* / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics* / Q000503:physiopathology; D011401:Promoter Regions, Genetic; D014157:Transcription Factors; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured
D014157:Transcription Factors; D007335:Insulin-Like Growth Factor II